Home > Research > Publications & Outputs > Priorities for cancer prevention

Research

Links

Text available via DOI:

Keywords

View graph of relations

Priorities for cancer prevention

Research output: Contribution to Journal/Magazine › Letter

Published

Standard

Priorities for cancer prevention. / Page, Jamie; Whaley, Paul; Watterson, Andrew et al.
In: Lancet Oncology, Vol. 13, No. 6, 06.2012, p. e230.

Research output: Contribution to Journal/Magazine › Letter

Harvard

Page, J, Whaley, P, Watterson, A & Clapp, R 2012, 'Priorities for cancer prevention', Lancet Oncology, vol. 13, no. 6, pp. e230. https://doi.org/10.1016/S1470-2045(12)70140-7

APA

Page, J., Whaley, P., Watterson, A., & Clapp, R. (2012). Priorities for cancer prevention. Lancet Oncology, 13(6), e230. https://doi.org/10.1016/S1470-2045(12)70140-7

Vancouver

Page J, Whaley P, Watterson A, Clapp R. Priorities for cancer prevention. Lancet Oncology. 2012 Jun;13(6):e230. doi: 10.1016/S1470-2045(12)70140-7

Author

Page, Jamie ; Whaley, Paul ; Watterson, Andrew et al. / Priorities for cancer prevention. In: Lancet Oncology. 2012 ; Vol. 13, No. 6. pp. e230.

Bibtex

@article{53f2b6ded2a543e88e400931d9a1649f,
title = "Priorities for cancer prevention",
keywords = "Carcinogens, Environmental, Environmental Exposure, Humans, Life Style, Neoplasms, Risk Reduction Behavior",
author = "Jamie Page and Paul Whaley and Andrew Watterson and Richard Clapp",
year = "2012",
month = jun,
doi = "10.1016/S1470-2045(12)70140-7",
language = "English",
volume = "13",
pages = "e230",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Priorities for cancer prevention

AU - Page, Jamie

AU - Whaley, Paul

AU - Watterson, Andrew

AU - Clapp, Richard

PY - 2012/6

Y1 - 2012/6

KW - Carcinogens, Environmental

KW - Environmental Exposure

KW - Humans

KW - Life Style

KW - Neoplasms

KW - Risk Reduction Behavior

U2 - 10.1016/S1470-2045(12)70140-7

DO - 10.1016/S1470-2045(12)70140-7

M3 - Letter

C2 - 22652231

VL - 13

SP - e230

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 6

ER -